Publisher： John Wiley & Sons Inc
E-ISSN： 1365-2265|82|4|557-561
ISSN： 0300-0664
Source： CLINICAL ENDOCRINOLOGY, Vol.82, Iss.4, 2015-04, pp. : 557-561
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Half‐life extended factor VIII for the treatment of hemophilia A
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. :
Access to resources
Recommend
Temporal variations of antipyrine half‐life in man
CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 22, Iss. 6, 1977-12 ,pp. :
THE CONCEPT OF BIOLOGIC HALF‐LIFE IN RELATION TO SENESCENCE
JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 17, Iss. 10, 1969-10 ,pp. :
Transition considerations for extended half‐life factor products
HAEMOPHILIA, Vol. 21, Iss. 3, 2015-05 ,pp. :